

Disease-Specific Resources
New TMPRSS2-Expressing Cell Line for COVID-19 Research
- Updated Offerings
- April 23, 2020
- Madison Knapp
We are offering a brand new cell line to assist researchers in the fight against COVID-19.The cell line (JCRB1819), developed...
What is ADME and how does it fit into drug development?
- Test Systems & Methods
- April 10, 2020
- Madison Knapp, Dr. Brian Ogilvie
The main aim of drug development is to get a compound that has a therapeutic effect into the form of...
New Liver Tissue Microarrays Available – What Would Benefit Your Research?
- Disease-Specific Resources
- April 2, 2019
- Madison Knapp, Dr. Maciej Czerwinski
As technology evolves to better meet needs in exploration of drug metabolism pathways and disease mechanisms, familiarization with appropriate and...
Disease-State Test Systems
- Test Systems & Methods
- January 13, 2019
- Michael Millhollen, Dr. Chris Bohl
SEKISUI XenoTech has been working with and supplying reagents for the pre-clinical ADME field for well over two decades. Years...
New Liver Disease Resource and Other Research Biobank News
- Updated Offerings
- May 26, 2017
- Michael Millhollen, Dr. Maciej Czerwinski
SEKISUI XenoTech is committed to furthering the knowledge surrounding hepatic diseases, which affects one out of four people worldwide, such...
SEKISUI XenoTech Joins Fight Against Liver Disease
- Disease-Specific Resources
- September 16, 2016
- Dr. Maciej Czerwinski, Michael Millhollen
SEKISUI XenoTech is committed to furthering the knowledge surrounding hepatic diseases, such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic...
Learn more
about SEKISUI XenoTech’s Research BioBank
